IMV Inc.

IMVIFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$23423

P/E Ratio—

52W High$0.01

52W Low$0.00001

Avg Volume79

Open$0.00

Beta0.30

Free Cash Flow Financials Revenue

IMV Inc. (IMVIF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

IMVIF · free cash flow · updated Jun 8, 2026

Core FCF metrics

IMVIF · FCF · TTM · margin & CAGR

Free cash flow was −$33.1M for FY2022 (fiscal year ending 2022-12-31), up 0.1% year-over-year

FY2022 Free Cash Flow−$33.1M▲ +0.1% YoY

Trailing 12M (TTM)−$33.9Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

IMVIF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2022Latest−$32.1M(1M)−$33.1M▲ +0.1%—

FY2021−$31.8M(1M)−$33.2M▼ 32.0%—

FY2020−$24.8M(0M)−$25.1M▼ 17.3%—

FY2019−$28.0M(0M)−$21.4M▼ 10.9%—

FY2018−$17.1M(2M)−$19.3M▼ 102.7%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

IMVIF · P/FCF · FCF yield · FCF per share

IMV Inc. (IMVIF) reported negative free cash flow of −$0.03B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2022 · 2022-12-31

Cash flow statement summary

IMVIF · cash flow statement · operating / investing / financing

For FY2022, IMV Inc. generated −$32.1M in operating cash flow and spent 1M in capital expenditures, yielding −$33.1M in free cash flow.

Operating Activities

−$32.1M

Cash from core business operations

2022-12-31

Investing Activities

−$1.0M

CapEx, acquisitions & investments

2022-12-31

Financing Activities

+$16.7M

Buybacks, dividends & debt

2022-12-31

FCF FormulaOperating CF (−$32.1M) − |CapEx| (1M) = FCF (−$33.1M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

IMVIF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

IMV Inc.YOU

IMVIF

−$33.1M+0.1%—

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

IMV Inc. (IMVIF) reported free cash flow of −$33.1M for FY2022 (fiscal year ending 2022-12-31), up 0.1% year-over-year.

IMV Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 14 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

IMVIF free cash flow · 8 questions

IMV Inc. free cash flow was −$33.1M for FY2022, up 0.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$33.9M.

IMVIF free cash flowIMVIF FCFIMVIF FCF 2022IMVIF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · IMV Inc. · IMV Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026